Dr. Rachel Katz-Brull, Director of the Center for Hyperpolarized MRI Molecular Imaging at the Hadassah Medical Center, has been awarded a 1,650,000 euro grant by the European Research Council to investigate the effectiveness of a non-radioactive substance in detecting cancer via imaging–a substance discovered by Dr. Katz-Brull and her colleagues.

If this non-radioactive substance proves effective, however, it can be used on children and pregnant women, as well as other patients who need to avoid exposure to radioactive substances.

Read the full story in The Jerusalem Post. http://www.jpost.com/Health-and-Science/Despite-settlement-row-EU-to-fund-research-into-cancer-treatment-320547

Share on FacebookTweet about this on TwitterShare on Google+Pin on PinterestEmail this to someone